Position in AZN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$10,669,538
-$262,366 QoQ
Shares Held
56,268
+1.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#300
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $193,149,306 across 14 Drug Manufacturers - General names. AZN ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,944 | $56,306,046 | |
| 2 | JNJ |
Johnson & Johnson
|
174,910 | $44,421,892 | |
| 3 | ABBV |
AbbVie Inc.
|
96,118 | $24,187,133 | |
| 4 | NVO |
Novo Nordisk A S
|
308,903 | $14,808,809 | |
| 5 | MRK |
Merck & Co., Inc.
|
102,060 | $13,114,710 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
56,268 | $10,669,538 | |
| 7 | AMGN |
Amgen Inc
|
26,804 | $9,706,264 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
71,841 | $9,076,391 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,669,538 | 56,268 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $10,931,904 | 55,430 | Shares | Sole | 2026-04-14 | |
| No filing history on record for this holder in this stock. | ||||||